Involvement of Cytochromes P450 2D6, 2B6 and 2C19 in the Metabolism of (-)-Deprenyl and N-Methyl,N-propargylphenylethylamine
Drug Metabolism Letters · 2007
DOI: 10.2174/187231207780363589 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Drug Metabolism Letters, 2007. Verfasst von K A Rittenbach und 1 weiteren Autor:innen. Beteiligte Einrichtung: Neurochemical Research Unit, Department of Psychiatry, 1E7 Mackenzie Centre, University of Alberta, Edmonton, Alberta, Canada. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
The metabolism of (-)-deprenyl (N-methyl,N-propargylamphetamine) and N-methyl,N-propargylphenyl-ethylamine (MPPE), monoamine oxidase inhibitors with neuroprotective properties, was studied using human liver microsomes and cDNA-expressed cytochrome P450 (CYP) enzymes. The metabolic pathways of MPPE parallel those of (-)-deprenyl, but some marked differences were observed, particularly with regard to the contributions of CYP2B6 and CYP2D6.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Neurochemical Research Unit, Department of Psychiatry, 1E7 Mackenzie Centre, University of Alberta, Edmonton, Alberta, Canada.
Zitieren
APA
Rittenbach, K. A., & Baker, G. B. (2007). Involvement of Cytochromes P450 2D6, 2B6 and 2C19 in the Metabolism of (-)-Deprenyl and N-Methyl,N-propargylphenylethylamine. Drug Metabolism Letters. https://doi.org/10.2174/187231207780363589
Vancouver
Rittenbach KA, Baker GB. Involvement of Cytochromes P450 2D6, 2B6 and 2C19 in the Metabolism of (-)-Deprenyl and N-Methyl,N-propargylphenylethylamine. Drug Metabolism Letters. 2007. doi:10.2174/187231207780363589
BibTeX
@article{Rittenbach2007,
author = {Rittenbach, K A and Baker, G B},
title = {Involvement of Cytochromes P450 2D6, 2B6 and 2C19 in the Metabolism of (-)-Deprenyl and N-Methyl,N-propargylphenylethylamine},
journal = {Drug Metabolism Letters},
year = {2007},
doi = {10.2174/187231207780363589}
}
EUVIMED